Current Treatment Challenges
Even the best treatments don’t work if patients don’t take them
Pressure from payers for improved adherence is driving the need to innovate novel solutions in drug delivery; with only 61.4% of patients actually taking their medication 1 , non-adherence costs the United States, alone, more than $100B annually 2. In addition to the pain and compliance issues associated with injections and infusions, the delivery profile is often non-optimal, negatively affecting treatment outcomes. Oral delivery via pills does not have the pain associated with injections and infusions, yet still suffers from poor adherence. Extended release implants address all of these issues head on, and likely improve patient outcomes.
Nano Precision Medical is developing a biocompatible, miniaturized,, subdermal implant with the NanoPortal TM membrane to provide long-term, substantially constant-rate delivery of therapeutic macromolecules for up to a year.
Pain, No Gain
Current Standard Therapy
Difficulty with adherence
Frequent, uncomfortable treatments lead to reduced patient compliance and suboptimal outcomes.
Lack of efficacy
Diminished concentrations between treatments can limit treatment efficacy.
Unnecessary side effects
Spikes in concentration immediately following treatments often cause toxicity and undesirable patient side effects.
Worry-Free, Constant-Rate Delivery
NanoPortal Eliminates the Need for Frequent Administration
Clinicians and insurance providers can trust that patients receive their prescribed treatment, maximizing the chance for positive outcomes.
Consistent delivery rates eliminate concentration spikes and diminished concentrations, overcoming the pharmacokinetic inadequacies of standard therapy.
Patients can be confident that they will receive their medication for many months without any need for continual oversight.
The NanoPortal TM Solution
Nano Precision Medical is developing a small, miniturized implant with the NanoPortal membrane to provide long-term, constant-rate delivery of therapeutics for many months. The rice-grain sized device is designed for easy implantation under the skin.
Easy to implant
Our miniturized device can be implanted in minutes during a simple, outpatient procedure.
Our potent formulation permits an extended duration of therapy to fit into a compact device.
Biocompatible, titania, nanoporous membrane technology enables constant-rate release without moving parts or electronics.